Skip to main content
. 2016 Feb 23;7(12):15065–15092. doi: 10.18632/oncotarget.7604

Figure 1. CTHRC1 mRNA expression in benign and malignant melanocytic lesions and cells, and other cell types.

Figure 1

A. Relative CTHRC1 expression levels in benign nevi and primary melanomas in two independent sample sets. CTHRC1 and RPLP0 cDNA levels were measured using qRT-PCR in triplicate for each sample. Bars represent standard deviations. *P = 0.0147, **P = 0.000907. B. CTHRC1 expression in cultures of different primary normal and melanoma cells, and melanoma cell lines. CTHRC1 and RPLP0 cDNA levels were measured using qRT-PCR in triplicate for each sample. CTHRC1/RPLP0 levels are shown relative to that of WM239.